Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
Equities
603707
CNE100002WP3
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.36 CNY | -0.89% | -2.84% | -10.93% |
08:04am | Hybio Pharmaceutical Gets Nod to Market Ganirelix Acetate Injection | MT |
May. 13 | NKFPharma's Unit Gets FDA's Nod to Market Eptifibatide Injection in US | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.93% | 3B | |
+37.89% | 727B | |
-7.94% | 354B | |
+15.55% | 328B | |
-0.45% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.94% | 164B | |
-2.04% | 164B |
- Stock Market
- Equities
- 603707 Stock
- News Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
- NKFPharma's Unit Gets FDA's Nod to Market Eptifibatide Injection in US